iBio, Inc. (IBIO) Operating margin 2016–2025
iBio, Inc. (IBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-4650.5%FY2025 · since FY2016: -1043.6% → -4650.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4650.5% | +2742.4 pp |
| FY2024 | -7392.9% | — |
| FY2022 | -1576.3% | -264.1 pp |
| FY2021 | -1312.1% | -457.3 pp |
| FY2020 | -854.9% | -72.5 pp |
| FY2019 | -782.4% | +2421.9 pp |
| FY2018 | -3204.3% | +418.6 pp |
| FY2017 | -3622.8% | -2579.3 pp |
| FY2016 | -1043.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice